Interaction of JC virus (JCV) T-antigen with key growth regulatory pathways

Interaction of JC virus (JCV) T-antigen with key growth regulatory pathways. JCV large T-antigen (T-Ag) is believed to drive the oncogenic process of malignant transformation by associating with several cellular proteins. T-Ag has the capacity to interact with two tumour suppressor proteins that regulate cell cycle progression, pRb and p53. (A) Under normal physiological conditions, pRb is maintained in a hypophosphorylated state and sequesters the S phase specific transcription factor E2F-1, in a pRb:E2F-1 complex. On JCV infection, T-Ag binds to the pRb protein releasing E2F-1, permitting it to induce cellular proliferation by promoting transcription of S phase genes. E2F-1 induces p14ARF gene expression, which interferes with the activity of MDM2, a negative regulator of p53 protein. Consequently, p53 is stabilised, which would inhibit the cell cycle and promote apoptosis (see fig 6 for additional details). (B) T-Ag binds to and inactivates p53, which prevents inhibition of the cell cycle or apoptosis. (C) T-Ag binds to IRS-1, a key member of the IGF signalling pathway, leading to uncoupling of IGF-1R from IRS-1, and its translocation to the nucleus. In the nucleus, IRS-1 may be important in Rad51 trafficking and homologous recombination directed DNA repair. (D) Finally, T-Ag can be oncogenic by deregulating the Wnt signalling pathway. In normal cells, β-catenin levels are regulated by a multiprotein complex of GSK3β, Axin-1, and APC, which phosphorylate β-catenin and trigger its degradation. On JCV infection, T-Ag binds to β-catenin, leading to its stabilisation, and providing a nuclear localisation signal. Once in the nucleus, stabilised β-catenin complexes with transcription factors such as TCR/LEF, which stimulates the transcription of cell cycle regulatory genes, including c-myc and cyclin D1.
Interaction of JC virus (JCV) T-antigen with key growth regulatory pathways

Publication

INFECTION, INFLAMMATION, AND GASTROINTESTINAL CANCER. (2005) C R Boland, et al. Gut. 2005 Sep;54(9):1321-1331. Figure: F2.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Danio rerio Vertebrates p53 P53 ncbigene_synonym tp53 30590
Danio rerio Vertebrates E2F-1 E2F1 ncbigene_symbol e2f1 101885420
Danio rerio Vertebrates c-myc, C-MYC ncbigene_synonym myca 30686
Danio rerio Vertebrates cyclinD1, CCND1 ncbigene_symbol ccnd1 30222
Danio rerio Vertebrates MDM2 MDM2 ncbigene_symbol mdm2 30637
Danio rerio Vertebrates B-catenin CTNNB1 ncbigene_symbol ctnnb1 30265
Danio rerio Vertebrates IRS-1 IRS1 ncbigene_symbol irs1 559281
Danio rerio Vertebrates IGF-IR IGF-IR ncbigene_synonym igf1rb 245702
Homo sapiens Primates T-Ag TAG ncbigene_synonym TMED7 51014
Homo sapiens Primates T-Ag TAG ncbigene_synonym LINC01194 404663
Homo sapiens Primates pRb PRB ncbigene_synonym RB1 5925
Homo sapiens Primates p53 P53 ncbigene_synonym TP53 7157
Homo sapiens Primates p53 P53 famplex_relations TP63 8626
Homo sapiens Primates p53 P53 famplex_relations TP73 7161
Homo sapiens Primates E2F-1 E2F-1 ncbigene_synonym E2F1 1869
Homo sapiens Primates c-myc, C-MYC ncbigene_synonym MYC 4609
Homo sapiens Primates cyclinD1, CCND1 ncbigene_symbol CCND1 595
Homo sapiens Primates p14 P14 ncbigene_synonym CDKN2A 1029
Homo sapiens Primates p14 P14 ncbigene_synonym S100A9 6280
Homo sapiens Primates p14 P14 ncbigene_synonym CDK2AP2 10263
Homo sapiens Primates p14 P14 ncbigene_synonym SUB1 10923
Homo sapiens Primates p14 P14 ncbigene_synonym RPP14 11102
Homo sapiens Primates p14 P14 ncbigene_synonym LAMTOR2 28956
Homo sapiens Primates p14 P14 ncbigene_synonym SF3B6 51639
Homo sapiens Primates p14 P14 ncbigene_synonym H3P8 115482693
Homo sapiens Primates MDM2 MDM2 ncbigene_symbol MDM2 4193
Homo sapiens Primates B-catenin CTNNB1 ncbigene_symbol CTNNB1 1499
Homo sapiens Primates IRS-1 IRS1 ncbigene_symbol IRS1 3667
Homo sapiens Primates IGF-IR IGFIR ncbigene_synonym IGF1R 3480

Chemical mentions

Word Match MeSH Name ChEBI

Disease mentions

Word Match MeSH Name DOID